All stock lists
HSBC Holdings, plc. (New York Stock Exchange:HSBC)
GB · Delayed Price · Currency is USD
Financial Services · Banks - Diversified
86.01-5.20 (-5.70%)
Market cap
$295B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 16, 1999
Website
Insider Score
––Not scored
HSBC Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From HSBC’s reported statements · Q2 2026 (trailing 12 months)
Profitability19 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $134.51B
- Net income
- $25.49B
- Net margin
- 18.9%
Leverage20 / 20
Little or no net debt.
- Total debt
- $132.90B
- Cash
- $227.80B
- Net debt / EBITDA
- -2.39x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $633.96B
- Current liabilities
- $1998.19B
- Current ratio
- 0.32
Cash generation11 / 20
Roughly cash-neutral.
- Operating cash flow
- $0
- Free cash flow
- $0
- FCF margin
- 0.0%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 3425.8M
- Share growth (1y)
- -2.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
HSBC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 34.16 B | 33.84 B | 33.03 B | 33.48 B | 33.73 B | 33.85 B |
| Revenue Growth (YoY) | 1.26 % | -0.04 % | -4.45 % | -8.37 % | -42.57 % | -7.59 % |
| Cost of Revenue | 15.12 B | 14.71 B | 15.31 B | 15.58 B | 16.08 B | 16.11 B |
| Gross Profit | 19.04 B | 19.13 B | 17.72 B | 17.90 B | 17.66 B | 17.74 B |
| SG&A Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 8.90 B | 9.75 B | 10.92 B | 10.61 B | 11.33 B | 8.26 B |
| Operating Income | 10.15 B | 9.38 B | 6.80 B | 7.29 B | 6.33 B | 9.48 B |
| Pretax Income | 10.15 B | 9.38 B | 6.80 B | 7.29 B | 6.33 B | 9.48 B |
| Tax Provision | 2.22 B | 1.98 B | 1.61 B | 1.79 B | 1.46 B | 1.91 B |
| Net Income | 7.91 B | 7.34 B | 4.94 B | 5.28 B | 4.73 B | 7.32 B |
| EPS (Basic) | 2.25 | 2.00 | 1.35 | 1.40 | 1.30 | 1.95 |
| EPS (Diluted) | 2.20 | 2.00 | 1.35 | 1.40 | 1.30 | 1.95 |
| Shares Outstanding | 3.43 B | 3.43 B | 3.42 B | 3.46 B | 3.50 B | 3.55 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.